From: Co-infection and enterovirus B: post EV-A71 mass vaccination scenario in China
Virus | Total (n = 459) | P | |
---|---|---|---|
No | % | ||
Enterovirus infection | 348 | 75.82 | Â |
 Average age | 2.80 ± 1.90 |  | |
 Single enterovirus infection | 191 | 41.61 | < 0.01 |
Enterovirus A | 119 | 25.9 | Â |
 CVA6 | 52 | 11.33 | < 0.01 |
 CVA4 | 24 | 5.23 | < 0.01 |
 CVA16 | 16 | 3.49 | < 0.01 |
 CVA10 | 9 | 1.96 | 0.786 |
 CVA5 | 9 | 1.96 | – |
 EV71 | 2 | 0.44 | < 0.01 |
 Other Enterovirus A | 9 | 1.96 | 0.786 |
Enterovirus B | 72 | 15.7 | Â |
 CVB1 | 41 | 8.93 | < 0.01 |
 CVA9 | 21 | 4.58 | < 0.01 |
 Other Enterovirus B | 10 | 2.18 | 0.031 |
Co-infection | 157 | 34.20 | < 0.01 |
 EV71 + other EVs (except CVA6 + CVA16) | 9 | 1.96 | – |
 CVA6 + other EVs (except EV71 + CVA16) | 70 | 15.25 | < 0.01 |
 CVA6 + CVA16 + other EVs (except EV71) | 7 | 1.53 | 0.661 |
 CVA16 + other EVs (except EV71 + CVA6) | 46 | 10.02 | < 0.01 |
 Other EVs | 25 | 5.01 | < 0.01 |
Non-enterovirus infection | 111 | 24.18 | Â |